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Abstract Aim: To produce a totally allogeneic graft material that would eliminate
the need for harvesting the autogenous bone from patients.
Materials and methods: Thirty-six (10  5 mm) defects were created in the parietal
bones of 18 rabbits. Two experimental groups of 12 defects each were grafted with
DBMIM alone and VEGF þ DBMIM, respectively. The remaining 12 defects were left
empty as controls, and sacrificed on days 14, 30 and 60. Two rabbits, with four de-
fects, of each group were sacrificed on day 14, 30 and 60 post grafting. The defects
were retrieved for histological evaluation and quantitative analysis.
Results: No bone formed across the defect in the controls. The difference in the
amount of new bone formation between experimental groups was significant
especially 30 and 60 days post grafting (p < 0.0001), which were 149% and 100%
respectively.
Conclusion: VEGF þ DBMIM powder is a promising graft material, and warrants
further clinical investigation.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Alveolar bone defects caused by trauma, bone
pathology, early loss of teeth or during extraction
of buccally placed teeth, require restoration. The
selection of ideal bone graft material to restore
form, esthetic and function during repair of non-
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E-mail address: fyoung@hkucc.hku.hk (R.W.K. Wong).1743-9191/$ - see front matter ª 2006 Surgical Associates Ltd. Pu
doi:10.1016/j.ijsu.2006.04.005regenerative defects is an important aspect in
modern surgery.1 Endochondral (EC) grafts usually
taken from the iliac crest, are the most widely
used graft material.2 In experimental studies au-
togenous EC grafts lost 65% of their volume.3 On
the other hand, autogenous intramembranous
(IM) grafts, usually taken from chin, retromolar
area and parietal bone were reported to retain
volume better than EC grafts, and it was concluded
that rapid vascularization of IM grafts might be
the cause of its greater volume maintenance overblished by Elsevier Ltd. All rights reserved.
VEGF augments the healing of DBM 161EC grafts.3e5 It was also stated that in healing
of bone grafts, a significant correlation exists
between the temporal sequence of vascularization
and the eventual viability and incorporation of the
graft.6
However, autogenous bone grafts have disad-
vantages such as limited availability of the donor
tissue, donor site morbidity, difficulty in providing
the desired shape, besides it requires general
anesthesia and hospitalization, which is also
costly.7
Clinical studies have successfully used deminer-
alized bone matrix (DBM) as bone graft material for
the treatment of acquired and congenital cranio-
maxillofacial and orthopedic defects.8 However,
the attempted reconstruction of large skeletal
defects by implanting DBM alone resulted in non-
union.9,10 To overcome this problem, Rabie and
co-workers investigated the use of composite DBM
either IMorECoriginwithautogenousbonegrafts.11,12
This combination produced much more new bone
than did autogenous bone grafts alone.1,13e15
Another method used to help the weak integra-
tion of EC bone grafts is by the addition of growth
factors,16,17 an angiogenic activator was locally
administrated to EC demineralized allogeneic bone
grafts for repair of segmental defects in rats. The
angiogenic treated group showed 80% overall in-
crease in bone density as well as twofold increase
in regional blood perfusion.
Also the use of basic fibroblast growth factor
(bFGF) with corticocancellous autografts for re-
construction of irradiated mandibular resection
sites was evaluated by microangiographic, histo-
logical, and bone-labeling techniques in rabbits.18
Healing and re-establishment of mandibular con-
tour occurred in 50% of the animals. It was con-
cluded from these works that growth factors
may augment the inductive capacity of bone
grafts.16e18 More recently, human recombinant
bFGF was found to greatly augment the inductive
capacity of allogeneic bone grafts in the rabbit
mandibular defect model.19
Finally, Ferrara and Davis-Smyth examined vascu-
larendothelial growthfactor (VEGF)whichwas found
to promote the growth of endothelial cells isolated
from bovine adrenal cortex, cerebral cortex, fetal
and adult aorta and human umbilical vein.20
The objectives of the current study were to
examine the use of DBM prepared from IM bone
(DBMIM) mixed with vascular endothelial growth
factor (VEGF) and to compare new bone formation
qualitatively and quantitatively with the use of
DBMIM alone in order to produce a totally allogeneic
material that would eliminate the need for harvest-
ing autogenous bone from patients.Materials and methods
Experimental groups
Eighteen adult New Zealand White rabbits, with
mean weight of 3.5 kg were used as experimental
models. Twenty-four critical size (10  5 mm),
full thickness bony defects were created in the
parietal bones of 12 rabbits (Fig. 1), they were
further divided into two groups:
 Group A, in which 12 defects were packed with
DBMIM particles mixed with whole blood;
 Group B, in which 12 defects were packed with
DBMIM particles mixed with VEGF.
Of the 12 experimental rabbits two of each
group were sacrificed on days 14, 30 and 60 post
grafting.
In the remaining 6 rabbits, 12 critical size
(10  5 mm), full thickness bony defects were
created (2 bony defects in each rabbit), and were
used as controls. The defects in the control group
were left empty. Control rabbits were sacrificed
on days 14, 30 and 60.
Preparation of rabbit DBMIM powder
DBMIM was prepared following the method re-
ported earlier by Rabie et al.21 Fresh IM bone
was excised from the parietal bones of New Zealand
White rabbits, fresh bones, free of bone marrow,
soft tissues and periosteum, were rinsed in
phosphate buffered saline (PBS) with protease
Figure 1 Schematic diagram of dorsal view of rabbit
skull, showing the location of two surgically created
defects and the five regions within the defect from
which sections were drawn for quantitative analysis.
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and diethyl ether. The cleaned bones were frozen
in liquid nitrogen and pulverized in a liquid nitro-
gen-cooled analytical mill (IKA Labortechnik, Janke
& Kunkel-Str. 10, D-79219 Staufen, Germany). The
resulting powder was sieved to give a particle size
of 0.25 mm. Fifty milliliters of 0.5 M HCl and pro-
tease inhibitors were added to each gram of bone
powder; the powder was then dialyzed (Visking
tubing, size 5, MW 12 kDa; Medicell International
Ltd, 239 Liverpool Rd, London, N1 1LX, UK) against
0.5 M HCl for 3 h and distilled water overnight to
remove calcium hydroxyapatite from bone matrix.
The demineralized bone matrix was then pelleted,
dried and stored in sterile glass tubes.
Reconstitution of human
recombinant VEGF
Lyophilized human recombinant VEGF expressed in
sf 21 insect cell (>97% purity; product No.v7259;
Sigma, USA) was reconstituted with sterile phos-
phate-buffered saline containing with 0.1% bovine
serum albumin. In the group grafted with VEGF-
DBMIM, 1250 ng/500 ml human recombinant VEGF
mixed with 500 mg DBMIM powder were placed in
each defect.
Surgical procedure
Premedication
The animals were premedicated 1 h prior to the
surgery with cefoperazone sodium (Cefobid Pfizer
Egypt SAE) (30 mg/kg body weight), and 20 min
before surgery with atropine sulfate (0.2 mg/kg)
were given intramuscularly.
Anesthsesia
A combination of ketamine hydrochloride (50 mg/
kg), and xylazine (3 mg/kg) were given by intra-
muscular injection.
Defect creation
A total of 10  5 mm, full thickness bony defects,
devoid of periosteum, were created using surgical
templates in the parietal bones. The defects were
packed as mentioned for each experimental group
and left empty in the control group. All wounds
were closed with interrupted 3-0 black silk sutures.
No attempts were made to approximate the
periosteum.
Postoperative care
The rabbits were given an antibiotic (Cefobid Pfizer
Egypt SAE) (30 mg/kg), and given NSAID (Orudis) forpain relief. At 14, 30, and 60 days postoperative an-
imals were sacrificed, and the defect areas, includ-
ing the surrounding tissue, were harvested for
histological preparation and examination.
Histological evaluation and quantitative
analysis
The specimenswere fixed in 10% neutral phosphate-
buffered formalin, decalcified in K’s decal fluid
(sodium formate/formic acid, clinical pathology
unit, central armed force labs) for 2 days and
double embedded in paraffin. Specimens were
trimmed to expose the complete surfaces. Some
serial sections were stained routinely with hema-
toxylin and eosin. The specimens were qualitatively
evaluated with a light transmitting microscope
(BH-2 Olympus).
About 50e80 serial sections were taken serially
for thickness of 6 mm each in one specimen. Each
specimen was divided into five regions (AeE).
Each region was represented by 10e16 glass slides.
Among them, two glass slides each region were
taken randomly to be stained with the periodic
acid-Schiff (PAS) reaction technique to show new
bone trabecular architecture and mineralized
matrix, and cover-slipped in histological medium
Permount (Fisher Scientific, 1 Reagent Lane Fairlawn,
NJ 07410 USA). These sections were selected for
quantitative analysis with a computer-assisted
image analyzing system (Leica Q5501W; Leica
Microsystems Imaging Solutions Ltd., Clifton R,
Cambridge CB1 3QH,UK) with software (Leica
Q-win Pro., Version 2.2). Differences in PAS stain-
ing properties and morphology between newly
formed bone and host bone were easy to distin-
guish in a Q-win computer-assisted image analyzer.
Statistical methods
Data were analyzed with statistical computer
software (Graphpad Instat, V.3.02, 1997, San
Diego, USA). The arithmetic mean and standard
deviation (SD) were calculated for each experi-
mental group. The means of each group were
analyzed with the t-test, with p < 0.05 chosen as
the critical level of statistical significance.
The size of the method error in digitizing the
area of new bone was calculated by the formulaﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sd2=2n
p
where d is the difference between the
two registrations and n is the number of double
registrations. Ten randomly drawn histological
sections were digitized on two separate occasions
at least 1 month apart by the same observer and
also by an independent observer. Paired t-tests
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observer registrations.
Results
Clinical and physical examinations
All animals remained in good health throughout
the course of the experiment. There was no
evidence of infection in any of the animals.
Gross appearance
The defects in the non-grafted group exhibited no
bone formation, as evidenced by soften on palpa-
tion. Defects implanted with either DBMIM or
VEGF þ DBMIM were hard to palpate. During collec-
tion of the specimens the group grafted with
VEGF þ DBMIM after 30 and 60 days exhibited thick-
ening of the covering periosteum and the color was
a deeper red compared with the DBMIM group and
the same group after 14 days.
Histological findings
Control group
The defects from the control group were filled
with fibrous connective tissue. Occasionally, a
narrow margin of new bone can be seen adjacent
to the host bone (Fig. 2).
Fourteen days post grafting
Scattered new bone was interposed around DBMIM
particles in the DBMIM alone group (Fig. 3a), while
more new bone was evident in the VEGF þ DBMIM
group (Fig. 3b).Thirty and 60 days post grafting
Only a small amount of the new bone was localized
near host bone in the DBMIM alone groups (Figs. 4a,
5a), while an abundant amount of new bone
bridged between two sides of the host bone in
the VEGF þ DBMIM group (Figs. 4b, 5b).
Quantitative analysis
A total of 240 tissue sections from experimental
samples were digitized in the Leica Q-win system
(Fig. 6). Table 1 shows the difference of newly
formed bone between defects of DBMIM bone grafts
and that of VEGF þ DBMIM composite bone grafts
after 14, 30 and 60 days post grafting. An extremely
significant difference (p < 0.0001) was found after
30 and 60 days post grafting, which were 149% and
100% respectively.
Figure 2 Histological evaluation of the defects of con-
trol group (left empty) 14 days post grafting. It was filled
with fibrous connective tissue with little new bone for-
mation. H, host bone.Figure 3 Histological evaluation of the defects 14 days post grafting. (a) Grafted with DBMIM alone; (b) grafted with
VEGF þ DBMIM. H, host bone; N, new bone; D, DBMIM particle.
164 B. Emad et al.Figure 4 Histological evaluation of the defects 30 days post grafting. (a) Grafted with DBMIM alone; (b) grafted with
VEGF þ DBMIM. N, new bone; D, DBMIM particle.For the method error analysis, 10 sections were
drawn at random and digitized, and the readings
were then compared. The method error of the
image analysis did not exceed 0.014 mm2, which
was insignificant compared with the results. Hy-
pothesis testing indicated no significant difference
among the duplicate intra-observe (p ¼ 0.565) and
inter-observer registrations (p ¼ 0.591) of the 10
randomly drawn sections.
Discussion
This study succeeded in creating a graft material
that is totally allogeneic and more osteoinductive
than DBM alone. This allogeneic graft material
consisted of DBMIM augmented with VEGF. This is
shown by the results of the p value; the difference
in the amount of new bone formation between
study groups was statistically significant especially
30 and 60 days post grafting (p < 0.0001),
which were 149% and 100% respectively (Table 1,
Fig. 6).Earlier it was reported that DBMIM was more
osteoinductive than DBMEC and its osteoinductivity
was ascribed to (1) osteoinductive factors ex-
tracted from IM bone demonstrated the ability to
induce new bone formation without a cartilage
intermediate stage.21,22 (2) It induces earlier and
extensive vascularization.23 (3) IM autogenous
bone produced 166%more bone than EC autogenous
bone.1 Therefore it is not surprising to see that the
DBM prepared from IM bone produces more bone
than the DBM produced from EC bone.
However the attempted reconstruction of large
skeletal defects by implanting demineralized bone
matrix alone resulted in non-union.9,10 Therefore
it is not recommended to use DBM alone in the
case of large skeletal defects.
Neovascularization by angiogenesis is consid-
ered a key step in the success of bone graft
healing. The degree of revascularization is related
to the stimuli present in the surrounding tissue
that allow pre-existing vessels to start budding into
the freely applied grafts. Therefore in this study it
was planned to add VEGF with DBMIM.Figure 5 Histological evaluation of the defects 60 days post grafting. (a) Grafted with DBMIM alone; (b) grafted with
VEGF þ DBMIM. H, host bone; N, new bone.
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Gerber et al.24 inactivated VEGF through the sys-
temic administration of a soluble receptor chimeric
protein in 24-day-old mice. Blood vessel invasion
was almost completely suppressed, concomitant
with impaired trabecular bone formation and
expansion of the hypertrophic chondrocyte zone.
Cessation of the anti-VEGF treatment was followed
by capillary invasion, restoration of bone growth,
resorption of the hypertrophic cartilage, and nor-
malization of the growth plate architecture. These
findings indicated that VEGF-mediated capillary
invasion is an essential signal that regulates bone
growth. Bone growth and bone repair are regulated
by the same processes therefore VEGF should have
similar effect during bone repair.
Mayr-Wohlfart et al.25 have shown that the vas-
cular endothelial growth factor stimulates chemo-
tactic migration of primary human osteoblasts and
compared this with the effects of human basic
fibroblast growth factor (bFGF) and human bone
morphogenic protein-2 (BMP-2). The maximal
effect observed was a chemotactic index (CI) of
2 at a concentration of 10 ng/ml. Basic-FGF and
BMP-2 exhibited maximum at 1.0 ng/ml with CI
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Figure 6 Comparison of area of newly formed bone
between defects of DBMIM bone grafts and that of
DBMIM þ VEGF composite bone graft (mm2) after 14, 30
and 60 days of engraftment. *p< 0.05; ***p< 0.001.values of 2.5 and 2, respectively. In addition to
its effect on cell migration, VEGF stimulated cell
proliferation up to 70%. This data establishes that
human osteoblasts respond to VEGF, suggesting
a functional role for this growth factor in bone
formation and remodeling.
Another possible explanation of the enhanced
osteogenesis seen in VEGF group is the greater
amount of neovascularization that provides a valu-
able source of non-differentiated mesenchymal
cells, which exist in the perivascular sites.26 These
mesenchymal cells are then acted upon by the
bone morphogenic proteins (BMPs) present in the
DBMIM,
21 causes their differentiation into osteopro-
genitor cells,26 and osteogenesis proceeds.
As neovascularization started earlier in the
VEGF group, it is expected that maturation takes
place earlier as well. This provides sufficient
amount of non-differentiated cells at the right
time to be acted upon by BMP before being washed
out, as multinucleated osteoclasts remodel the
newly formed bone by day 12e18, resulting in
selective dissolution of the implanted matrix.
This might also explain why the amount of new
bone formation was more significant in the spec-
imens taken after 30 and 60 days as the formed
woven bone is remodeled and progressively re-
placed by the nutrient-demanding mature lamellar
bone and the hematopoietic bone marrow, which
is the origin of osteoprogenitor cells. The greater
the vascularity of the graft, the greater the num-
ber of osteoprogenitor cells and nutrition, the
greater the bone formation and remodeling, and
hence the better the quality and quantity of the
formed bone. Therefore the addition of VEGF to
DBMIM improves the quality and quantity of newly
formed bone in the grafted site.
In conclusion, we succeeded in producing a graft
material that is easy to obtain and eliminates the
need to harvest bone from the patient, as this study
showed that VEGF þ DBMIM is a good graft material
and warrants further clinical investigation.Table 1 Comparison of area of newly formed bone between defects of DBMIM bone grafts and that of
DBMIM þ VEGF composite bone graft (mm2) after 14, 30 and 60 days of engraftment
Days 14 30 60
DBMIM DBMIM þ
VEGF
DBMIM DBMIM þ
VEGF
DBMIM DBMIM þ
VEGF
Mean 0.25 0.90 0.47 1.17 1.02 2.04
SD 0.12 0.46 0.13 0.09 0.14 0.53
Diff. 0.65 0.70 1.02
p-valuea 0.016 <0.0001 <0.0001
a t-test.
166 B. Emad et al.References
1. Rabie ABM, Wong RWK, Hagg U. Bone induction using autog-
enous bone mixed with demineralised bone matrices. Aust
Orthod J 1999;15:269e75.
2. Burchardt H. Biology of bone transplantation. Orthop Clin
North Am 1987;18:187e96.
3. Zins JE, Whitaker LA. Membranous versus endochondral
bone: implications for craniofacial reconstruction. Plast Re-
constr Surg 1983;72:778e85.
4. Kusiak JF, Zins JE, Whitaker LA. The early revascularization
of membranous bone. Plast Reconstr Surg 1985;76:510e6.
5. Phillips JH, Rahn BA. Fixation effects on membranous and
endochondral onlay bone-graft resorption. Plast Reconstr
Surg 1988;82:872e7.
6. Eppley BL, Doucet M, Connolly DT. Enhancement of angio-
genesis by bFGF in mandibular bone graft healing in the
rabbit. J Oral Maxillofac Surg 1988;46:391e8.
7. Younger EM, Chapman MW. Morbidity at bone graft donor
sites. J Orthop Trauma 1989;3:192e5.
8. Glowacki J, Kaban LB, Murray JE, Folkman J, Mulliken JB.
Application of the biological principle of induced osteogen-
esis for craniofacial defects. Lancet 1981;1:959e62.
9. Tuli SM, Singh AD. The osteoinductive property of decalci-
fied bone matrix. An experimental study. J Bone Joint
Surg 1978;60:116e23.
10. Wittbjer J, Palmer B, Rohlin M. Osteogenetic activity in
composite grafts of demineralized compact bone and
marrow. Clin Orthop 1983;173:229e38.
11. Rabie ABM, Deng YM, Samman N. The effect of demineral-
ized bone matrix on the healing of intramembranous bone
grafts in rabbit skull defects. J Dent Res 1996;75:1045e51.
12. Rabie ABM, Lie KJRK. Integration of endochondral bone
grafts in the presence of demineralized bone matrix. Int J
Oral Maxillofac Surg 1996;25:311e8.
13. RabieABM.Molecular andbiochemical advances in thefiledof
clinical bone induction. In: Rabie ABM,Urist MR, editors.Bone
formation and repair. Amsterdam: Elsevier; 1997. p. 89e100.
14. Rabie ABM. Vascular endothelial growth pattern during
demineralized bone matrix induced osteogenesis. Connect
Tissue Res 1997;36:337e45.15. Rabie ABM, Wong RWK, Hagg U. Composite autogenous bone
and demineralized bone matrices used to repair defects in
the parietal bone of rabbits. Br J Oral Maxillofac Surg
2000;38:565e70.
16. Marden LJ, Reddi AH, Hollinger JO. Growth and differen-
tiation factors: role in bone induction and potential appli-
cation in craniofacial surgery. J Craniofac Surg 1990;1:
154e60.
17. Nottebaert M, Lane JM, Juhn A. Omental angiogenic lipid
fraction and bone repair. An experimental study in the
rat. J Orthop Res 1989;7:157e69.
18. Eppley BL, Connolly DT, Winkelmann T. Free bone graft
reconstruction of irradiated facial tissue: experimental
effects of basic fibroblast growth factor stimulation. Plast
Reconstr Surg 1991;88:1e11.
19. Lu M, Rabie AB. The effect of demineralized intramembra-
nous bone matrix and basic fibroblast growth factor on the
healing of allogeneic intramembranous bone grafts in the
rabbit. Arch Oral Biol 2002;47:831e41.
20. Ferrara N, Davis-Smyth T. The biology of vascular endothe-
lial growth factor. Endocr Rev 1997;18:4e25.
21. Reddi AH, Huggins C. Biochemical sequences in the trans-
formation of normal fibroblasts in adolescent rats. Proc
Natl Acad Sci U S A 1972;69:601e5.
22. Scott CK, Hightower JA. The matrix of endochondral bone
differs from the matrix of intramembranous bone. Calcif
Tissue Int 1991;49:349e54.
23. Rabie ABM, Chow KM, Wong RWK. Demineralized intramem-
branous bone matrix augments the healing of endochondral
bone graft. Int J Adult Orthodon Orthognath Surg 1999;14:
185e97.
24. Gerber HP, Vu TH, Ryan AM, Kowalski J, Hillan KJ, Werb Z,
et al. VEGF couples hypertrophic cartilage remodeling,
ossification and angiogenesis during endochondral bone
formation. Nat Med 1999;5:623e8.
25. Mayr-Wohlfart U, Waltenberger J, Hausser H. Vascular
endothelial growth factor stimulates chemotactic migration
of primary human osteoblasts. Bone 2002;30:472e7.
26. Urist MR. Bone morphogenetic protein, bone regeneration,
heterotopic ossification and the bone-bone marrow consor-
tium. In: Peck WA, editor. Bone and mineral research, 6.
Amsterdam: Elsevier; 1989. p. 57.
